Deon Venter to speak at Pathology Horizons 2016

 

deon-venter-1 We are delighted to announce that Professor Deon Venter will join our speaker panel at  Pathology Horizons in Galway 15-17th of September 2016.

Deon  pioneered the use of genomic technologies in cancer diagnostics and research in Australasia. He is Director of Pathology at Mater Health Services in Brisbane and the  author on over 100 peer-reviewed publications, primarily in the fields of cancer genetics and genetic-based diagnostics. His other contributions include being the first to demonstrate the expression of the HER2 protein on the cell membrane of breast cancer cells, which identified this molecule as a viable target for developing the drug Herceptin. Always pioneering, he is the first Australasian MD to have his genome sequenced.

Deon will discuss using whole genome and exome sequences to solve cases of perinatal death which otherwise proved unsolvable.  Via collaboration with colleagues at the Erasmus Medical Center Rotterdam, he will explain how a  a bioinformatics pipeline has been developed to aid the processing of such sequencing data.

Pathology Horizons 2016

Pathology Horizons is an open annual conference organised and sponsored by Cirdan  to discuss developing technologies and trends in Pathology. The dates are 15-17 September in the stunning west of Ireland in Galway.

This unique event will give you the  chance to learn about the potential impacts and challenges of new diagnostic and informatics technologies on pathology.

Topics will include genetic marking, molecular pathology, the future of imaging, data analytics and the laboratory, integration and mobile connectivity across laboratory systems. There will also be the chance to see some cutting edge solutions in action.

Other Speakers

Prof Ian Young | Chief Scientific Advisor, Health Dept N.Ireland

Prof Richard Levenson | UC Davis, California

Prof Eric Glassy| AFMG, Los Angeles

Prof Fabio Grizzi | Humanities Research Centre, Milan

Dr Raymond Bond | University of Ulster

Dr Laura Elnitski | Nat Human Genome Research Institute, MD, USA

Colin Truesdale | Marketing Manager, Kainos Evolve

Dr David Snead | Head – UHCW NHS Digital Pathology Centre of Excellence

Dr Glenn Edwards | National Medical Director, St John of God Pathology, Perth, Australia

Prof Tim Helliwell | Clinical Director Cellular Pathology, Liverpool Clinical Laboratories

Judy Fitzgerald | Project Manager, Cirdan, Brisbane, Australia

Leave a Reply

This site uses Akismet to reduce spam. Learn how your comment data is processed.